Monthly Program - February 14, 2012
Worcester Polytechnic Institute
Campus Center - Odeum Room
Doors open for networking: 5:30 p.m.
Meeting: 6:30 – 8:30 p.m.
Cost: Free for members, $15 for WPI alumni, $30 general public
Pre-registration
Parking
David S. Miller, Ph.D.
War Stories in Finance
Any start-up entrepreneur can tell you a few war stories about financing their venture. David S. Miller, Ph.D. can tell you dozens. Founder and Executive Managing Director of angel investors Clean Energy Venture Group (CEVG), Miller will be the keynote speaker for the WPI Venture Forum’s February 14 meeting, where he will address the critical criteria required to provide financing for energy startups. With more than 20 years of technology experience and 10 years of seed stage investing under his belt, Miller has plenty of wisdom to share with the Valentine’s Day audience at WPI.
An engineer by training, Miller is on the board of directors or advisory board of several clean energy companies, including Azima DLI, Next Step Living, MyEnergy, and Cambrian Innovation, and has mentored many others. He is also a research affiliate at MIT’s Sloan School of Management. A founding member of the MIT Enterprise Forum’s Energy Special Interest Group, he has chaired the mentor program for what is now the Northeast Cleantech Open for more than four years.
Miller also co-founded EPrime, a forum for clean energy entrepreneurs to network and support each other’s enterprises. He previously founded several companies, including Quantum Telecom Solutions, which developed software for programmable switching equipment. He negotiated venture financing for it and sold the company to a division of Lucent Technologies. Miller was awarded a patent for co-developing a “one number” telecom service.
John Anderson, CFO
Case Presentation: Pharma-Cycle Inc.
Cancer patients return home after chemotherapy treatment only to endanger their families and local drinking water supplies with the toxic chemicals that pass through their bodies. Pharma-Cycle (PCI) has developed patent pending devices to neutralize and sequester these dangerous drugs, and is creating a service system to safely collect the stabilized wastes from patients’ homes and oncology clinics.
Presenting the case will be PCI’s Chief Financial Officer, John Anderson, together with Chief Scientific Officer Theresa O’Keefe, Ph.D. Anderson has more than 30 years of experience and has run three chemical waste companies in locations across North America. O’Keefe has developed antibody drugs for inflammatory and oncology diseases, co-founded Waltham Technologies, and holds more than 25 patents.
Theresa O'Keefe, Ph.D.
Last modified: January 12, 2012 15:20:02